Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Understanding the pharmacology of stroke and multiple sclerosis through imaging.
Feasibility and Findings from a Novel Working Memory fMRI Paradigm in Multiple Sclerosis.
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Tamoxifen promotes differentiation of oligodendrocyte progenitors in vitro.
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Erratum to: The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
White Matter Injury in Ischemic Stroke.
Interventions for children coping with parental multiple sclerosis: A systematic review.
Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis.
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Development of the Oxford Participation and Activities Questionnaire: constructing an item pool.
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons.
Lentivirus-Mediated RNA Interference Targeting RhoA Slacks the Migration, Proliferation, and Myelin Formation of Schwann Cells.
Pages
« first
‹ previous
…
567
568
569
570
571
572
573
574
575
…
next ›
last »